Patents by Inventor Robert E. Atkinson

Robert E. Atkinson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10806487
    Abstract: Devices and methods for the treatment of chronic total occlusions are provided. One disclosed embodiment comprises a method of facilitating treatment via a vascular wall defining a vascular lumen containing an occlusion therein. The method includes inserting an intramural crossing device into the vascular lumen, positioning at least the distal tip of the crossing device in the vascular wall, advancing an orienting device over the crossing device such that an orienting element of the orienting device resides in the vascular wall, inserting a reentry device, and re-entering the true vascular lumen.
    Type: Grant
    Filed: September 14, 2017
    Date of Patent: October 20, 2020
    Assignee: BridgePoint Medical, Inc.
    Inventors: Chad J. Kugler, Robert E. Atkinson, Matthew J. Olson
  • Publication number: 20200316373
    Abstract: A method including chronically implanting a nerve cuff electrode on a portion of a hypoglossal nerve, chronically implanting a respiration sensing lead subcutaneously in a thorax of a patient, the respiration sensing lead having a plurality of bio-impedance electrodes defining at least one bio-impedance vector. The method may also include sensing a bio-impedance signal corresponding to respiration via a bio-impedance vector on an anterior side of the thorax, analyzing the bio-impedance signal to identify onsets of expiration, predicting an onset of a future expiratory phase, and delivering a stimulus to the portion of the hypoglossal nerve via the nerve cuff electrode, wherein the stimulus is delivered as a function of the bio-impedance signal; wherein stimulus delivery is initiated before the onset of the future expiratory phase and continued during an entire inspiratory phase, and wherein the method is performed without identifying an onset of an inspiratory phase.
    Type: Application
    Filed: April 16, 2020
    Publication date: October 8, 2020
    Applicant: LivaNova USA, Inc.
    Inventors: Stephen L. Bolea, Thomas B. Hoegh, Bruce J. Persson, Robert E. Atkinson, Scott T. Mazar
  • Publication number: 20200254245
    Abstract: An implantable neurostimulation system comprises a stimulation delivery lead and a neurostimulator. The stimulation delivery lead is coupled to an electrode. The neurostimulator is adapted to deliver a neurostimulation signal to the subject and comprises a microprocessor. The microprocessor is programmed to identify a stimulation operating window for the therapy including a first threshold and a second threshold. The second threshold comprises an awake level and an asleep level. Identifying the stimulation operating window comprises titrating a stimulation setting of the neurostimulator while the subject is awake until the first threshold and the awake level of the second threshold are identified. Identifying the stimulation operating window further comprises subsequently repeating the step of titrating the stimulation setting of the neurostimulator while the subject is asleep until the asleep level of the second threshold is identified.
    Type: Application
    Filed: April 24, 2020
    Publication date: August 13, 2020
    Applicant: LivaNova USA, Inc.
    Inventors: Stephen L. Bolea, Thomas B. Hoegh, Brian D. Kuhnley, Dale G. Suilmann, Bruce J. Persson, John P. Beck, Sidney Hauschild, Paula M. Kaplan, Adam K. Hoyhtya, Wondimeneh Tesfayesus, Robert E. Atkinson, Peter R. Eastwood, David R. Hillman
  • Patent number: 10737094
    Abstract: Devices, systems and methods of neurostimulation for treating obstructive sleep apnea.
    Type: Grant
    Filed: October 18, 2018
    Date of Patent: August 11, 2020
    Assignee: LivaNova USA, Inc.
    Inventors: Stephen L. Bolea, Thomas B. Hoegh, Brian D. Kuhnley, Dale G. Suilmann, Bruce J. Persson, John P. Beck, Sidney F. Hauschild, Paula M. Kaplan, Adam K. Hoyhtya, Wondimeneh Tesfayesus, Robert E. Atkinson
  • Patent number: 10632308
    Abstract: A method including chronically implanting a nerve cuff electrode on a portion of a hypoglossal nerve, chronically implanting a respiration sensing lead subcutaneously in a thorax of a patient, the respiration sensing lead having a plurality of bio-impedance electrodes defining at least one bio-impedance vector. The method may also include sensing a bio-impedance signal corresponding to respiration via a bio-impedance vector on an anterior side of the thorax, analyzing the bio-impedance signal to identify onsets of expiration, predicting an onset of a future expiratory phase, and delivering a stimulus to the portion of the hypoglossal nerve via the nerve cuff electrode, wherein the stimulus is delivered as a function of the bio-impedance signal; wherein stimulus delivery is initiated before the onset of the future expiratory phase and continued during an entire inspiratory phase, and wherein the method is performed without identifying an onset of an inspiratory phase.
    Type: Grant
    Filed: July 31, 2017
    Date of Patent: April 28, 2020
    Assignee: LivaNova USA, Inc.
    Inventors: Stephen L. Bolea, Thomas B. Hoegh, Bruce J. Persson, Robert E. Atkinson, Scott T. Mazar
  • Patent number: 10632306
    Abstract: Devices, systems and methods of neurostimulation for treating obstructive sleep apnea.
    Type: Grant
    Filed: August 25, 2017
    Date of Patent: April 28, 2020
    Assignee: LivaNova USA, Inc.
    Inventors: Stephen L. Bolea, Thomas B. Hoegh, Brian D. Kuhnley, Dale G. Suilmann, Bruce J. Persson, John P. Beck, Sidney Hauschild, Paula M. Kaplan, Adam K. Hoyhtya, Wondimeneh Tesfayesus, Robert E. Atkinson, Peter R. Eastwood, David R. Hillman
  • Publication number: 20200014079
    Abstract: Disclosed is a method of: providing an electrochemical energy storage device having a first electrode and a second electrode; and simultaneously: a) maintaining the first electrode and a first temperature; b) maintaining the second electrode at a second temperature; and c) charging or discharging the device. The coolest portion of the second electrode is at least 1° C. warmer than the warmest portion of the first electrode.
    Type: Application
    Filed: July 8, 2019
    Publication date: January 9, 2020
    Applicant: The Government of the United States of America, as represented by the Secretary of the Navy
    Inventors: Corey T. Love, Rachel E. Carter, Robert W Atkinson
  • Publication number: 20190269434
    Abstract: Devices and methods for the treatment of chronic total occlusions are provided. One disclosed embodiment comprises a method of facilitating treatment via a vascular wall defining a vascular lumen containing an occlusion therein. The method includes providing an intravascular device having a distal portion with a side port, inserting the device into the vascular lumen, positioning the distal portion in the vascular wall, directing the distal portion within the vascular wall such that the distal portion moves at least partially laterally, and directing the side port towards the vascular lumen.
    Type: Application
    Filed: May 22, 2019
    Publication date: September 5, 2019
    Applicant: BRIDGEPOINT MEDICAL, INC.
    Inventors: CHAD J. KUGLER, ROBERT E. ATKINSON
  • Publication number: 20190247628
    Abstract: Devices and methods for the treatment of chronic total occlusions are provided. One disclosed embodiment comprises a method of facilitating treatment via a vascular wall defining a vascular lumen containing an occlusion therein. The method includes providing an intravascular device having a distal portion with a lumen extending therein; inserting the device into the vascular lumen; positioning the distal portion in the vascular wall; and directing the distal portion within the vascular wall.
    Type: Application
    Filed: April 26, 2019
    Publication date: August 15, 2019
    Applicant: BRIDGEPOINT MEDICAL, INC.
    Inventors: CHAD J. KUGLER, ROBERT E. ATKINSON
  • Patent number: 10342569
    Abstract: Devices and methods for the treatment of chronic total occlusions are provided. One disclosed embodiment comprises a method of facilitating treatment via a vascular wall defining a vascular lumen containing an occlusion therein. The method includes providing an intravascular device having a distal portion with a side port, inserting the device into the vascular lumen, positioning the distal portion in the vascular wall, directing the distal portion within the vascular wall such that the distal portion moves at least partially laterally, and directing the side port towards the vascular lumen.
    Type: Grant
    Filed: April 4, 2011
    Date of Patent: July 9, 2019
    Assignee: BRIDGEPORT MEDICAL, INC.
    Inventors: Chad J. Kugler, Robert E. Atkinson
  • Patent number: 10315010
    Abstract: Devices and methods for the treatment of chronic total occlusions are provided. One disclosed embodiment comprises a method of facilitating treatment via a vascular wall defining a vascular lumen containing an occlusion therein. The method includes providing an intravascular device having a distal portion with a lumen extending therein; inserting the device into the vascular lumen; positioning the distal portion in the vascular wall; and directing the distal portion within the vascular wall.
    Type: Grant
    Filed: March 1, 2011
    Date of Patent: June 11, 2019
    Assignee: BRIDGEPOINT MEDICAL, INC.
    Inventors: Chad J. Kugler, Robert E. Atkinson
  • Publication number: 20190151656
    Abstract: Devices, systems and methods of neurostimulation for treating obstructive sleep apnea.
    Type: Application
    Filed: October 18, 2018
    Publication date: May 23, 2019
    Applicant: CYBERONICS, INC.
    Inventors: Stephen L. Bolea, Thomas B. Hoegh, Brian D. Kuhnley, Dale G. Suilmann, Bruce J. Persson, John P. Beck, Sidney F. Hauschild, Paula M. Kaplan, Adam K. Hoyhtya, Wondimeneh Tesfayesus, Robert E. Atkinson
  • Publication number: 20190090890
    Abstract: Devices and methods for the treatment of chronic total occlusions are provided. One disclosed embodiment comprises a method of facilitating treatment via a vascular wall defining a vascular lumen containing an occlusion therein. The method includes providing a first intravascular device having a distal portion with a concave side, inserting the first device into the vascular lumen, positioning the distal portion in the vascular wall, and orienting the concave side of the distal portion toward the vascular lumen.
    Type: Application
    Filed: November 27, 2018
    Publication date: March 28, 2019
    Applicant: BRIDGEPOINT MEDICAL, INC.
    Inventors: CHAD J. KUGLER, MATTHEW J. OLSON, ROBERT E. ATKINSON
  • Publication number: 20190059927
    Abstract: Devices and methods for the treatment of chronic total occlusions are provided. One disclosed embodiment comprises a method of facilitating treatment via a vascular wall defining a vascular lumen containing an occlusion therein. The method includes providing an intravascular device having a distal portion, inserting the device into the vascular lumen, positioning the distal portion in the vascular wall to at least partially surround the occlusion, and removing at least a portion of the surrounded occlusion from the lumen.
    Type: Application
    Filed: October 30, 2018
    Publication date: February 28, 2019
    Applicant: Bridgepoint Medical, Inc.
    Inventors: Chad J. Kugler, Robert E. Atkinson
  • Patent number: 10166035
    Abstract: Devices and methods for the treatment of chronic total occlusions are provided. One disclosed embodiment comprises a method of facilitating treatment via a vascular wall defining a vascular lumen containing an occlusion therein. The method includes providing a first intravascular device having a distal portion with a concave side, inserting the first device into the vascular lumen, positioning the distal portion in the vascular wall, and orienting the concave side of the distal portion toward the vascular lumen.
    Type: Grant
    Filed: March 7, 2016
    Date of Patent: January 1, 2019
    Assignee: BRIDGEPOINT MEDICAL, INC.
    Inventors: Chad J. Kugler, Matthew J. Olson, Robert E. Atkinson
  • Patent number: 10143487
    Abstract: Devices and methods for the treatment of chronic total occlusions are provided. One disclosed embodiment comprises a method of facilitating treatment via a vascular wall defining a vascular lumen containing an occlusion therein. The method includes providing an intravascular device having a distal portion, inserting the device into the vascular lumen, positioning the distal portion in the vascular wall to at least partially surround the occlusion, and removing at least a portion of the surrounded occlusion from the lumen.
    Type: Grant
    Filed: December 10, 2015
    Date of Patent: December 4, 2018
    Assignee: Bridgepoint Medical, Inc.
    Inventors: Chad J. Kugler, Robert E. Atkinson
  • Patent number: 10105538
    Abstract: Devices, systems and methods of neurostimulation for treating obstructive sleep apnea.
    Type: Grant
    Filed: December 29, 2010
    Date of Patent: October 23, 2018
    Assignee: Cyberonics, Inc.
    Inventors: Stephen L. Bolea, Thomas B. Hoegh, Brian D. Kuhnley, Dale G. Suilmann, Bruce J. Persson, John P. Beck, Sidney F. Hauschild, Paula M. Kaplan, Adam K. Hoyhtya, Wondimeneh Tesfayesus, Robert E. Atkinson
  • Publication number: 20180200512
    Abstract: Devices, systems and methods of neurostimulation for treating obstructive sleep apnea. The system is adapted to send an electrical signal from an implanted neurostimulator through a stimulation lead to a patient's nerve at an appropriate phase of the respiratory cycle based on input from a respiration sensing lead. External components are adapted for wireless communication with the neurostimulator. The neurostimulator is adapted to deliver therapeutic stimulation based on inputs.
    Type: Application
    Filed: March 12, 2018
    Publication date: July 19, 2018
    Applicant: Cyberonics, Inc.
    Inventors: Stephen L. Bolea, Thomas B. Hoegh, Brian D. Kuhnley, Dale G. Suilmann, Bruce J. Persson, John P. Beck, Sidney F. Hauschild, Wondimeneh Tesfayesus, Jason J. Skubitz, Mark R. Bosshard, Daniel A. Parrish, Robert E. Atkinson
  • Patent number: RE48024
    Abstract: Devices, systems and methods for nerve stimulation for OSA therapy.
    Type: Grant
    Filed: April 8, 2015
    Date of Patent: June 2, 2020
    Assignee: LivaNova USA, Inc.
    Inventors: Stephen L. Bolea, Thomas B. Hoegh, Bruce J. Persson, Robert E. Atkinson, Sidney F. Hauschild, Paula M. Kaplan, Brian D. Kuhnley, Keith E. Jasperson, Wondimeneh Tesfayesus, Christopher K. Thorp
  • Patent number: RE48025
    Abstract: In one embodiment, a method for maintaining patency of an upper airway of a patient to treat obstructive sleep apnea may include delivering an electrical stimulation to a portion of a superior laryngeal nerve via a nerve cuff when the nerve cuff is adjacent an external surface of the superior laryngeal nerve, the nerve cuff having a plurality of electrodes, wherein the nerve cuff is configured to be connected to an electrical stimulator via a stimulation lead.
    Type: Grant
    Filed: April 22, 2015
    Date of Patent: June 2, 2020
    Assignee: LivaNova USA, Inc.
    Inventors: Stephen L. Bolea, Thomas B. Hoegh, Bruce J. Persson, Robert E. Atkinson, Sidney F. Hauschild, Paula M. Kaplan, Brian D. Kuhnley, Keith E. Jasperson, Wondimeneh Tesfayesus, Christopher K. Thorp